AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
The twice daily tablet represents a significant step forward for patients with advanced breast cancer.
The twice daily tablet represents a significant step forward for patients with advanced breast cancer.
What's Your Reaction?
